Prostatic artery embolization in patients with benign prostatic hyperplasia: perfusion cone-beam CT to evaluate planning and treatment response.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
23 09 2020
23 09 2020
Historique:
received:
17
07
2020
accepted:
23
10
2020
entrez:
27
11
2020
pubmed:
28
11
2020
medline:
29
6
2021
Statut:
epublish
Résumé
This proof of concept is to evaluate the utility of perfusion cone-beam computed tomography (CT) in patients undergoing prostatic artery (PA) embolization (PAE) for benign prostatic hyperplasia (BPH) with moderate or severe-grade lower urinary tract symptoms (LUTS). PAE is a novel minimally invasive therapy and is both safe and effective procedure with low risks and high technical successes, making this procedure as the best alternative to surgery. A lot of technical changes would compromise clinical outcomes after procedure, including a variable prostate vascular anatomy, thin PA, and extensive atherosclerotic disease. The purpose of our study is to exploit the advantages of Perfusion Cone Beam Computed Tomography (CBCT) that could impact treatment and help interventional radiologists for treatment planning, diagnosis and for assessing the technical feasibility during PAE, mitigating the risk of nontarget embolization and suggesting clinical outcomes. Qualitative and quantitative clinical pre- and post-treatment values will be compared, to reach the best possible results.
Identifiants
pubmed: 33245070
doi: 10.23750/abm.v91i10-S.10260
pmc: PMC8023075
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2020013Références
J Vasc Interv Radiol. 2016 Aug;27(8):1115-22
pubmed: 27321890
J Vasc Interv Radiol. 2020 Jun;31(6):882-890
pubmed: 32249193
BJU Int. 2018 Nov;122(5):801-807
pubmed: 29727912
Cardiovasc Intervent Radiol. 2016 Mar;39(3):447-52
pubmed: 26474582
Med Oncol. 2017 Jun;34(6):113
pubmed: 28470535
Radiology. 2014 Mar;270(3):920-8
pubmed: 24475799
J Vasc Interv Radiol. 2019 May;30(5):627-637.e1
pubmed: 30926185
J Urol. 2007 Apr;177(4):1419-22
pubmed: 17382744
Cardiovasc Intervent Radiol. 2016 Apr;39(4):530-7
pubmed: 26486155
J Urol. 2017 Feb;197(2S):S189-S197
pubmed: 28012747
Radiology. 2017 Jan;282(1):271-280
pubmed: 27467466
World J Urol. 2019 Apr;37(4):719-725
pubmed: 30073391
Eur Radiol. 2019 Jan;29(1):287-298
pubmed: 29948079
Radiol Med. 2014 Jul;119(7):521-32
pubmed: 25012472
Gland Surg. 2018 Apr;7(2):188-199
pubmed: 29770312
J Vasc Interv Radiol. 2019 Sep;30(9):1471-1479.e3
pubmed: 31371136
J Urol. 2011 May;185(5):1793-803
pubmed: 21420124
Cardiovasc Intervent Radiol. 2017 Aug;40(8):1176-1184
pubmed: 28105497
Cardiovasc Intervent Radiol. 2019 Nov;42(11):1644-1648
pubmed: 31218410
Eur Urol. 2013 Apr;63(4):677-9; discussion 679-80
pubmed: 23158588
J Urol. 2008 Jul;180(1):246-9
pubmed: 18499179
J Vasc Interv Radiol. 2016 Nov;27(11):1686-1697.e8
pubmed: 27742235
Acta Radiol. 2018 Jun;59(6):681-687
pubmed: 28856901
J Vasc Interv Radiol. 2013 Nov;24(11):1603-7
pubmed: 23978461
Arch Intern Med. 2006 Nov 27;166(21):2381-7
pubmed: 17130393
J Vasc Interv Radiol. 2009 May;20(5):606-13
pubmed: 19345589
Presse Med. 2019 Apr;48(4):447-453
pubmed: 31047745
J Vasc Interv Radiol. 2017 Apr;28(4):517-521
pubmed: 28259503
Med Phys. 2008 Jul;35(7Part3):3414-3415
pubmed: 28512891
Eur Radiol. 2019 Sep;29(9):5022-5031
pubmed: 30788587
J Vasc Interv Radiol. 2014 Jan;25(1):47-52
pubmed: 24176946
J Vasc Interv Radiol. 2012 Nov;23(11):1403-15
pubmed: 23101913
Cardiovasc Intervent Radiol. 2016 Jan;39(1):111-6
pubmed: 26134039
Cardiovasc Intervent Radiol. 2013 Apr;36(2):403-11
pubmed: 23232858
Eur Radiol. 2016 Feb;26(2):381-9
pubmed: 26045345
AJNR Am J Neuroradiol. 2011 Sep;32(8):1525-31
pubmed: 21757522
Cardiovasc Intervent Radiol. 2014 Dec;37(6):1430-5
pubmed: 25189663
Prim Care. 2019 Jun;46(2):223-232
pubmed: 31030823
Prostate Int. 2017 Jun;5(2):41-46
pubmed: 28593165